SCHEMBL26247238

SCHEMBL26247238

CCOC(=O)C(C)(C)OC(=O)C(C)(C)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.43
CYP4A11 Q02928 3/20 0.43
PPARA Q07869 2/20 0.43
ABCB11 O95342 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
HTR2A P28223 1/20 0.43
PMP22 Q01453 1/20 0.43
ALDH1A1 P00352 2/20 0.39
PKM P14618 3/20 0.38
MMP8 P22894 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
MGAM O43451 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23292898 0.84 CYP4F2 (0.44) CYP4F2CYP4A11PPARAABCB11CYP1A2
SCHEMBL122175 0.84
SCHEMBL4672815 0.80 CYP4F2 (0.44) CYP4F2CYP4A11PPARAABCB11CYP1A2
SCHEMBL23581535 0.80 ALDH1A1 (0.52) CYP4F2CYP4A11PPARAABCB11CYP1A2
SCHEMBL4672818 0.80 ALDH1A1 (0.50) CYP4F2CYP4A11PPARAABCB11CYP1A2
Formaldehyde SCHEMBL25432583 0.79 CYP4F2 (0.44) CYP4F2CYP4A11PPARAABCB11CYP1A2
SCHEMBL13843603 0.79 NAAA (0.44) CYP4F2CYP4A11CYP3A4TSHRALDH1A1
SCHEMBL4678703 0.78 CYP4F2 (0.43) CYP4F2CYP4A11PPARAABCB11CYP1A2
SCHEMBL22356277 0.78 ALOX15 (0.52) CYP4F2CYP4A11PPARAABCB11CYP1A2
SCHEMBL6620811 0.78 ABCB11 (0.47) CYP4F2CYP4A11PPARAABCB11CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025859-A1 PROCESSES OF MAKING 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES Translatum Medicus Inc. (CA) 2024-01-25 US disclosed
US-11753382-B2 Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives Translatum Medicus Inc. (CA) 2023-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753382-B2 Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives PCMT1, ICMT, FNTA CYP4F2 950/4885CYP4A11 1229/4885PPARA 2277/4885
US-20240025859-A1 PROCESSES OF MAKING 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES PCMT1, ICMT, FNTA CYP4F2 950/4885CYP4A11 1229/4885PPARA 2277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.